High Ezrin Expression Is Linked To Poor Prognosis and Drug Resistance in Estrogen Receptor-Positive Breast Cancer

被引：0
|
作者：
Vanna, Sonal [1 ]
Hoskin, Victoria [1 ]
Ghaffari, Abdi [1 ]
Madarnas, Yolanda [1 ]
SenGupta, Sandip [1 ]
Elliott, Bruce [1 ]
机构：
[1] Queens Univ, Kingston, ON, Canada
来源：
LABORATORY INVESTIGATION | 2015年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
274
引用
收藏
页码：71A / 71A
页数：1
相关论文
共 50 条
  • [1] High Ezrin Expression Is Linked To Poor Prognosis and Drug Resistance in Estrogen Receptor-Positive Breast Cancer
    Varma, Sonal
    Hoskin, Victoria
    Ghaffari, Abdi
    Madarnas, Yolanda
    SenGupta, Sandip
    Elliott, Bruce
    MODERN PATHOLOGY, 2015, 28 : 71A - 71A
  • [2] High expression of steroid sulfatase mRNA predicts poor prognosis in patients with estrogen receptor-positive breast cancer
    Miyoshi, Y
    Ando, A
    Hasegawa, S
    Ishitobi, M
    Taguchi, T
    Tamaki, Y
    Noguchi, S
    CLINICAL CANCER RESEARCH, 2003, 9 (06) : 2288 - 2293
  • [3] MZB1 expression indicates poor prognosis in estrogen receptor-positive breast cancer
    Watanabe, Manabu
    Shibata, Masahiro
    Inaishi, Takahiro
    Ichikawa, Takahiro
    Soeda, Ikumi
    Miyajima, Noriyuki
    Takano, Yuko
    Takeuchi, Dai
    Tsunoda, Nobuyuki
    Kanda, Mitsuro
    Kikumori, Toyone
    Kodera, Yasuhiro
    Nagino, Masato
    ONCOLOGY LETTERS, 2020, 20 (05)
  • [4] Higher CD73 Expression Is Associated with Poor Prognosis in Estrogen Receptor-Positive Breast Cancer
    Katsuta, Eriko
    Dasgupta, Subhamoy
    Yan, Li
    Takabe, Kazuaki
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2018, 227 (04) : S34 - S34
  • [5] MiR-187 is a marker of poor prognosis in estrogen receptor-positive breast cancer
    Mulrane, Laoighse
    Madden, Stephen
    Brennan, Donal J.
    Mcgee, Sharon F.
    Jirstrom, Karin
    van't Veer, Laura
    Bernards, Rene
    Higgins, Des
    Gallagher, William M.
    O'Connor, Darran P.
    CANCER RESEARCH, 2010, 70
  • [6] Expression of Androgen Receptor in Estrogen Receptor-positive Breast Cancer
    Agrawal, Anil
    Ziolkowski, Piotr
    Grzebieniak, Zygmunt
    Jelen, Michal
    Bobinski, Piotr
    Agrawal, Siddarth
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2016, 24 (08) : 550 - 555
  • [7] TSPAN1 overexpression as an indicator of poor prognosis in estrogen receptor-positive breast cancer
    Liu, Xiangjuan
    Zhang, Jiahong
    Zhao, Jun
    Cheng, Yan
    Jiang, Dandan
    TRANSLATIONAL CANCER RESEARCH, 2024, 13 (08)
  • [8] Effect of Wnt5a on drug resistance in estrogen receptor-positive breast cancer
    Amioka, Ai
    Kadoya, Takayuki
    Sueoka, Satoshi
    Kobayashi, Yoshie
    Sasada, Shinsuke
    Emi, Akiko
    Masumoto, Norio
    Ito, Masaoki
    Okada, Morihito
    CANCER RESEARCH, 2021, 81 (04)
  • [9] Gene expression associated with endocrine therapy resistance in estrogen receptor-positive breast cancer
    Jones, Veronica
    Yin, Hongwei Holly
    Yuan, Yate-Ching
    Wang, Yongzhe
    Li, Sierra Min
    Aljaber, Dana
    Sanchez, Angelica
    Quinones, Christine
    Schmolze, Dan
    Yuan, Yuan
    Mortimer, Joanne
    Yee, Lisa
    Kruper, Laura
    Jovanovic-Talisman, Tijana
    Tomsic, Jerneja
    Sanchez, Nancy
    Chavez, Tanya
    O'Regan, Ruth M.
    Khan, Qamar J.
    Davis, Melissa
    Kalinsky, Kevin
    Meisel, Jane
    Kittles, Rick
    Rodriguez-Rodriguez, Lorna
    Seewaldt, Victoria
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [10] The impact of CBP expression in estrogen receptor-positive breast cancer
    Wafaa S. Ramadan
    Iman M. Talaat
    Mahmood Y. Hachim
    Annette Lischka
    Timo Gemoll
    Raafat El-Awady
    Clinical Epigenetics, 2021, 13
12345